CREBBP and Alzheimer disease: Recent studies suggest that abnormal CBP activity and excessive acetylation of downstream substrates (including but not limited to tau) occurs in human AD brain (7, 8) and can accelerate general protein aggregation and the formation of toxic amyloids (46).